When discussing the possibility of TAVR for a patient with COPD, it is crucial to consider the severity of their symptoms.  

The company will use the funds to follow up on what it learned from the REDUCE LAP-HF II clinical trial.

Siemens Healthineers splashed an FDA-approved SPECT/CT system June 12 at the 2022 annual meeting of the Society of Nuclear Medicine & Nuclear Imaging in Vancouver, B.C.

“We have finally been able to pinpoint one of the key reasons why the heart muscle wall thickens," one researcher said. 

Researchers presented their findings at the 2022 European Human Genetics Conference in Vienna. 

The study's authors examined data from nearly 23,000 patients who underwent transcatheter mitral valve repair from 2014 to 2018. 

Though TAVR was once never considered a treatment option for younger patients, it is becoming more common as time goes on. 

The recall includes more than 1,600 devices distributed from October 2006 to June 2021. Medtronic's HVAD system has already been associated with multiple issues, including a separate recall in 2021. 

The committee's approval comes days after the FDA shared details on a small number of trial participants who developed myocarditis or pericarditis after receiving the vaccine.  

“Many studies look at the risk of a single condition in relation to dementia, but health is more complex than that,” one researcher said.